EUVIMEDEUVIMED entdecken
Crossref

Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency

Charu Chaudhry iD

Journal of Medicinal Chemistry · 11.05.2023 · 66 (9) · 6239-6250

DOI: 10.1021/acs.jmedchem.2c02076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 27.04.2023. Verfasst von Charu Chaudhry. Beteiligte Einrichtung: Molecular & Cellular Pharmacology, Lead Discovery, Janssen Research and Development, LLC, Spring House, Pennsylvania 19477, United States. Hauptthemen laut MEDLINE: Proteolysis Targeting Chimera, Proteins. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Janssen Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis targeting chimeras (PROTACs), heterobifunctional protein degraders, have emerged as an exciting and transformative technology in chemical biology and drug discovery to degrade disease-causing proteins through co-opting of the ubiquitin-proteasome system (UPS). Here, we develop a mechanistic mathematical model for the use of irreversible covalent chemistry in targeted protein degradation (TPD) either to a target protein of interest (POI) or an E3 ligase ligand, considering the thermodynamic and kinetic factors governing ternary complex formation, ubiquitination, and degradation through the UPS. We highlight key advantages of covalency to the POI and E3 ligase and the underlying theoretical basis in the TPD reaction framework. We further identify regimes where covalency can serve to overcome weak binary binding affinities and improve the kinetics of ternary complex formation and degradation. Our results highlight the enhanced catalytic efficiency of covalent E3 PROTACs and thus their potential to improve the degradation of fast turnover targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteolysis Targeting ChimeraProteinsKineticsUbiquitin-Protein LigasesProteasome Endopeptidase ComplexUbiquitinationProteolysisThermodynamics

Substanzen

Proteolysis Targeting ChimeraProteinsUbiquitin-Protein LigasesProteasome Endopeptidase Complex

Autor:innen und Institutionen

  • Molecular & Cellular Pharmacology, Lead Discovery, Janssen Research and Development, LLC, Spring House, Pennsylvania 19477, United States.

ORCID-Profile: Charu Chaudhry

Förderung

  • Janssen Research and Development

Zitieren

APA

Chaudhry, C. (2023). Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency. Journal of Medicinal Chemistry, 66(9), 6239-6250. https://doi.org/10.1021/acs.jmedchem.2c02076

Vancouver

Chaudhry C. Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency. Journal of Medicinal Chemistry. 2023;66(9):6239-6250. doi:10.1021/acs.jmedchem.2c02076

BibTeX
@article{Chaudhry2023,
  author = {Chaudhry, Charu},
  title = {Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {9},
  pages = {6239--6250},
  doi = {10.1021/acs.jmedchem.2c02076}
}
Kostenlos starten →